Benzinga | Nov 9, 2021 11:31AM EST

Sonoma Pharmaceuticals And Dyamed Biotech Announce Expanded Long-Term Partnership For New Territories And Products In Southeast Asia

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its long-time partner, Dyamed Biotech Pte Ltd., announce a renewed and expanded long-term partnership for Singapore, Malaysia, Indonesia and Thailand for multiple indications using Sonoma's patented Microcyn(r) Technology.

Dyamed Biotech Pte Ltd., one of Sonoma's first international partners, successfully commercializes Dermacyn(r) Wound Care, Dermacyn(r) Scarless for Scar Reduction, and Dermacyn(r) Ezyma Spray for itch relief associated with atopic dermatitis. Dyamed expects to launch Ocucyn(r) Eye Care and Oracyn(r) Oral Care in 2022. The Dermacyn(r) line of products are widely used at many hospitals throughout Singapore and Malaysia.

"We are so pleased with the performance of the Dermacyn(r) line of products which have helped provide modern wound care for both acute and chronic wounds in our hospitals and health care facilities for many years. With the additional indications using the patented Microcyn(r) Technology for scar reduction and atopic dermatitis treatment, we have had many patients see positive results," said Dyamed Biotech Pte Ltd., CEO Theodore Tan.

"In addition, we look forward to the next year as we expand the Dermacyn(r) line of products for both eye and oral care in pharmacies and hospitals throughout Southeast Asia," Mr. Tan added.

Bruce Thornton, Chief Operating Officer of Sonoma Pharmaceuticals said, "Dyamed has been a valued partner since 2004 and we are excited to support the next chapter of this special partnership. With the addition of the new territories of Indonesia and Thailand and new oral and eye care products, we expect Dyamed to expand its reach into both hospitals and pharmacy care. We are continuously seeking to expand our network of international distributors with quality partners like Dyamed to increase the reach of Sonoma products worldwide."